These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
551 related items for PubMed ID: 30132535
1. Resveratrol inhibited the progression of human hepatocellular carcinoma by inducing autophagy via regulating p53 and the phosphoinositide 3‑kinase/protein kinase B pathway. Zhang B, Yin X, Sui S. Oncol Rep; 2018 Nov; 40(5):2758-2765. PubMed ID: 30132535 [Abstract] [Full Text] [Related]
2. Resveratrol inhibits proliferation and migration through SIRT1 mediated post‑translational modification of PI3K/AKT signaling in hepatocellular carcinoma cells. Chai R, Fu H, Zheng Z, Liu T, Ji S, Li G. Mol Med Rep; 2017 Dec; 16(6):8037-8044. PubMed ID: 28983625 [Abstract] [Full Text] [Related]
3. Isoliquiritigenin inhibits proliferation and metastasis of MKN28 gastric cancer cells by suppressing the PI3K/AKT/mTOR signaling pathway. Zhang XR, Wang SY, Sun W, Wei C. Mol Med Rep; 2018 Sep; 18(3):3429-3436. PubMed ID: 30066879 [Abstract] [Full Text] [Related]
4. Hydrogen sulfide promotes autophagy of hepatocellular carcinoma cells through the PI3K/Akt/mTOR signaling pathway. Wang SS, Chen YH, Chen N, Wang LJ, Chen DX, Weng HL, Dooley S, Ding HG. Cell Death Dis; 2017 Mar 23; 8(3):e2688. PubMed ID: 28333142 [Abstract] [Full Text] [Related]
5. Matrine derivative WM130 inhibits hepatocellular carcinoma by suppressing EGFR/ERK/MMP-2 and PTEN/AKT signaling pathways. Qian L, Liu Y, Xu Y, Ji W, Wu Q, Liu Y, Gao Q, Su C. Cancer Lett; 2015 Nov 01; 368(1):126-134. PubMed ID: 26259512 [Abstract] [Full Text] [Related]
6. Resveratrol suppresses human hepatocellular carcinoma via targeting HGF-c-Met signaling pathway. Gao F, Deng G, Liu W, Zhou K, Li M. Oncol Rep; 2017 Feb 01; 37(2):1203-1211. PubMed ID: 28075467 [Abstract] [Full Text] [Related]
8. Ophiopogonin‑B targets PTP1B to inhibit the malignant progression of hepatocellular carcinoma by regulating the PI3K/AKT and AMPK signaling pathways. Yuan F, Gao Q, Tang H, Shi J, Zhou Y. Mol Med Rep; 2022 Apr 01; 25(4):. PubMed ID: 35169857 [Abstract] [Full Text] [Related]
9. Capsaicin and sorafenib combination treatment exerts synergistic anti‑hepatocellular carcinoma activity by suppressing EGFR and PI3K/Akt/mTOR signaling. Dai N, Ye R, He Q, Guo P, Chen H, Zhang Q. Oncol Rep; 2018 Dec 01; 40(6):3235-3248. PubMed ID: 30272354 [Abstract] [Full Text] [Related]
12. MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway. He C, Dong X, Zhai B, Jiang X, Dong D, Li B, Jiang H, Xu S, Sun X. Oncotarget; 2015 Oct 06; 6(30):28867-81. PubMed ID: 26311740 [Abstract] [Full Text] [Related]
13. Resveratrol induces apoptosis and autophagy in T-cell acute lymphoblastic leukemia cells by inhibiting Akt/mTOR and activating p38-MAPK. Ge J, Liu Y, Li Q, Guo X, Gu L, Ma ZG, Zhu YP. Biomed Environ Sci; 2013 Nov 06; 26(11):902-11. PubMed ID: 24331535 [Abstract] [Full Text] [Related]
14. [Involvement of p38-p53 signal pathway in resveratrol-induced apoptosis in MCF-7 cells]. Zhang YH, Guo JG, Guo ZH, Xie SQ. Yao Xue Xue Bao; 2011 Nov 06; 46(11):1332-7. PubMed ID: 22260024 [Abstract] [Full Text] [Related]
15. Docetaxel promotes cell apoptosis and decreases SOX2 expression in CD133‑expressing hepatocellular carcinoma stem cells by suppressing the PI3K/AKT signaling pathway. Zhang X, Shao J, Li X, Cui L, Tan Z. Oncol Rep; 2019 Feb 06; 41(2):1067-1074. PubMed ID: 30483804 [Abstract] [Full Text] [Related]
16. Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway. Zhang DM, Liu JS, Deng LJ, Chen MF, Yiu A, Cao HH, Tian HY, Fung KP, Kurihara H, Pan JX, Ye WC. Carcinogenesis; 2013 Jun 06; 34(6):1331-42. PubMed ID: 23393227 [Abstract] [Full Text] [Related]